Rarity Bioscience

Rarity Bioscience, founded in 2021, is a spin-off company from Uppsala University aimed at further developing and commercializing the superRCA detection technology. The superRCA technology was first discovered and developed in 2015 by Dr. Ulf Landegren of the Molecular Tools Group at the Department of Immunology, Genetics, and Pathology. The initial goal was to continue the successful development of padlock probes and rolling circle amplification to generate secondary rolling structures capable of increasing the signal intensity of existing protocols.